Atara Biotherapeutics Stock Forward View - Price Action Indicator
| ATRA Stock | USD 4.45 0.14 3.05% |
Atara Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Atara Biotherapeutics stock prices and determine the direction of Atara Biotherapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Atara Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time the rsi of Atara Biotherapeutics' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.60) | EPS Estimate Current Year 3.01 | EPS Estimate Next Year 0.7133 | Wall Street Target Price 8.6667 | EPS Estimate Current Quarter (0.67) |
Using Atara Biotherapeutics hype-based prediction, you can estimate the value of Atara Biotherapeutics from the perspective of Atara Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Atara Biotherapeutics after-hype prediction price | USD 3.76 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Atara Biotherapeutics to cross-verify your projections. Atara Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Atara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Atara using various technical indicators. When you analyze Atara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.11) | (0.18) |
| Check Atara Biotherapeutics Volatility | Backtest Atara Biotherapeutics | Information Ratio |
Atara Biotherapeutics Trading Date Momentum
| On February 15 2026 Atara Biotherapeutics was traded for 4.45 at the closing time. The top price for the day was 4.68 and the lowest listed price was 4.45 . There was no trading activity during the period 0.0. Lack of trading volume on February 15, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Atara Biotherapeutics to competition |
Other Forecasting Options for Atara Biotherapeutics
For every potential investor in Atara, whether a beginner or expert, Atara Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Atara Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Atara. Basic forecasting techniques help filter out the noise by identifying Atara Biotherapeutics' price trends.Atara Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Atara Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Atara Biotherapeutics could also be used in its relative valuation, which is a method of valuing Atara Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Atara Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Atara Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Atara Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Atara Biotherapeutics stock market strength indicators, traders can identify Atara Biotherapeutics entry and exit signals to maximize returns.
Atara Biotherapeutics Risk Indicators
The analysis of Atara Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Atara Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting atara stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.4 | |||
| Standard Deviation | 9.59 | |||
| Variance | 91.91 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Atara Biotherapeutics
The number of cover stories for Atara Biotherapeutics depends on current market conditions and Atara Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Atara Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Atara Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Atara Biotherapeutics Short Properties
Atara Biotherapeutics' future price predictability will typically decrease when Atara Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Atara Biotherapeutics often depends not only on the future outlook of the potential Atara Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Atara Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 7.5 M | |
| Cash And Short Term Investments | 42.5 M |
Check out Historical Fundamental Analysis of Atara Biotherapeutics to cross-verify your projections. For information on how to trade Atara Stock refer to our How to Trade Atara Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atara Biotherapeutics. If investors know Atara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Atara Biotherapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 2.86 | Revenue Per Share 12.858 | Quarterly Revenue Growth (0.91) | Return On Assets 0.3086 | Return On Equity |
Understanding Atara Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Atara's accounting equity. The concept of intrinsic value - what Atara Biotherapeutics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Atara Biotherapeutics' price substantially above or below its fundamental value.
Understanding that Atara Biotherapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Atara Biotherapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Atara Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.